Stem Cells http://www.peprotech.com/
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


First published online August 4, 2005
Stem Cells Vol. 23 No. 10 November 2005, pp. 1479 -1488
doi:10.1634/stemcells.2004-0369; www.StemCells.com
© 2005 AlphaMed Press

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2004-0369v1
23/10/1479    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yanagisawa, A.
Right arrow Articles by Tomizuka, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yanagisawa, A.
Right arrow Articles by Tomizuka, K.

Generation of Chromosome-Specific Monoclonal Antibodies Using In Vitro–Differentiated Transchromosomic Mouse Embryonic Stem Cells

Ayano Yanagisawaa,b, Chisato Endoa, Katsuya Okawaa, Shingo Shitaraa,b, Hiroyuki Kugohb, Makoto Kakitania, Mitsuo Oshimurab, Kazuma Tomizukaa,b

a Pharmaceutical Research Laboratories, Pharmaceutical Division, Kirin Brewery Co., Ltd., Takasaki, Gunma, Japan;
b Department of Biomedical Science, Institute of Regenerative Medicine and Biofunction, Graduate School of Medicine, Tottori University, Yonago, Tottori, Japan

Key Words. Monoclonal antibody • Embryonic stem cell • Human chromosome • Neural cell • CD133

Correspondence: Kazuma Tomizuka, Ph.D., Pharmaceutical Research Laboratory, Pharmaceutical Division, Kirin Brewery Co., Ltd., 3 Miyahara-cho, Takasaki-shi, Gunma 370-1295, Japan. Telephone: 81-27-346-9934; Fax: 81-27-346-1971; e-mail: ktomizuka{at}kirin.co.jp

Monoclonal antibodies (MoAbs) recognizing lineage- and stage-specific human cell-surface antigens are valuable reagents for the characterization and isolation of various specialized cell populations derived from human embryonic stem cells (hESCs). In this report, we examined the use of in vitro differentiated transchromosomic mouse embryonic stem cells (TC-ESCs) as immunogens to obtain MoAbs against human cell-surface antigens. Immunization of a neural-cell population derived from differentiating human chromosome 4 and 11 TC-ESCs resulted in two chromosome-specific MoAbs, h4-neural1 and h11-neural1, respectively. The staining profiles of differentiated TC-ESCs and human embryonic carcinoma cells with these MoAbs were similar to the expression profile of nestin, a well-characterized intracellular marker for neural progenitor cells. We also described the successful purification and identification of the gene for h4-neural1 antigen (CD133, 4p15.32) with immunoaffinity chromatography. This procedure may have significant utility in generating MoAbs useful for understanding the mechanism that regulates the in vitro differentiation of hESCs.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS
http://www.peprotech.com/
Copyright © 2005 by AlphaMed Press.